Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Hicks

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Sexually Transmitted Diseases|June 13, 2014
Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIVAnna B Cope, Amanda M Crooks, Tammy Chin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationMichael J Vinikoor, Anna Cope, Cynthia L Gay, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 21, 2021
Pathogenesis of obstructive sleep apnea in people living with HIVJeremy E Orr, Bradley A Edwards, Christopher N Schmickl, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Rapid viral suppression using integrase inhibitors during acute HIV-1 infectionMehri S McKellar, Jessica R Keys, Lindsey M Filiatreau, et al.
JAMA|July 4, 2002
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing populationChristopher D Pilcher, J Todd McPherson, Peter A Leone, et al.
AIDS Research and Human Retroviruses|March 19, 2009
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudineRafael E Campo, Barbara A Da Silva, Laurent Cotte, et al.
HIV Clinical Trials|January 25, 2008
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patientsRobert L Murphy, Barbara A da Silva, Charles B Hicks, et al.
The Journal of Continuing Education in the Health Professions|September 27, 2014
VISION: a regional performance improvement initiative for HIV health care providersTheodore O Bruno, Charles B Hicks, Susanna Naggie, et al.
AIDS (London, England)|May 6, 2009
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersOlivier Lambotte, Guido Ferrari, Christiane Moog, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Sexually Transmitted Diseases|June 13, 2014
Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIVAnna B Cope, Amanda M Crooks, Tammy Chin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 15, 2013
Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationMichael J Vinikoor, Anna Cope, Cynthia L Gay, et al.
AIDS Research and Human Retroviruses|March 27, 2009
Comparison of once-daily fosamprenavir boosted with either 100 or 200 mg of ritonavir, in combination with abacavir/lamivudine: 96-week results from COL100758Charles B Hicks, Edwin DeJesus, Louis M Sloan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 21, 2021
Pathogenesis of obstructive sleep apnea in people living with HIVJeremy E Orr, Bradley A Edwards, Christopher N Schmickl, et al.
The Journal of Antimicrobial Chemotherapy|November 6, 2024
Rapid viral suppression using integrase inhibitors during acute HIV-1 infectionMehri S McKellar, Jessica R Keys, Lindsey M Filiatreau, et al.
JAMA|July 4, 2002
Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing populationChristopher D Pilcher, J Todd McPherson, Peter A Leone, et al.
AIDS Research and Human Retroviruses|March 19, 2009
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudineRafael E Campo, Barbara A Da Silva, Laurent Cotte, et al.
HIV Clinical Trials|January 25, 2008
Seven-year efficacy of a lopinavir/ritonavir-based regimen in antiretroviral-naïve HIV-1-infected patientsRobert L Murphy, Barbara A da Silva, Charles B Hicks, et al.
The Journal of Continuing Education in the Health Professions|September 27, 2014
VISION: a regional performance improvement initiative for HIV health care providersTheodore O Bruno, Charles B Hicks, Susanna Naggie, et al.
AIDS (London, England)|May 6, 2009
Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllersOlivier Lambotte, Guido Ferrari, Christiane Moog, et al.
Pageof 9